未登录

J

Janine Mahoney

La Trobe University

H指数:10

被引数:489

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Addition of Amitriptyline or Placebo to Speech Pathology for Inducible Laryngeal Obstruction: A Double-Blind Randomized Controlled Trial

阿米替林或安慰剂与言语病理学结合治疗可诱导性喉阻塞：一项双盲随机对照试验

The Journal of Allergy and Clinical Immunology: In Practice

IF6.6

2026-03-230

PRE

Inter-rater reliability of laryngoscopic visual criteria for diagnosis of inducible laryngeal obstruction

可诱导性喉阻塞诊断中喉镜视觉标准的评分者间信度

The Journal of Allergy and Clinical Immunology: In Practice

IF6.6

2025-12-030

PRE

Significance of Inducible Laryngeal Obstruction Phenotypes identified by Latent Class Analysis

诱导性喉部阻塞表型的意义：由潜在类别分析确定

The Journal of Allergy and Clinical Immunology: In Practice

IF0

2025-07-260

PRE

Investigation of exertional dyspnoea by cardiopulmonary exercise testing with continuous laryngoscopy

JOURNAL OF SCIENCE AND MEDICINE IN SPORT

IF3.4

2025-02-010

PRE

Identification of Vocal Cord Dysfunction Phenotypes by Latent Class Analysis

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Exploring Factors Impacting Engagement in Speech Pathology Intervention for Inducible Laryngeal Obstruction

探索影响诱导性喉阻塞言语病理干预参与度的因素

Journal of Voice

IF2.4

2024-04-010

PRE

Trait profiles in difficult-to-treat asthma: Clinical impact and response to systematic assessment

IF12

2023-03-279

OA

Laryngoscopy diagnosis of inducible laryngeal obstruction during supervised challenge for suspected anaphylaxis

CLINICAL AND EXPERIMENTAL ALLERGY

IF5.2

2022-05-103

PRE

Diagnostic and Therapeutic Outcomes Following Systematic Assessment of Patients with Concurrent Suspected Vocal Cord Dysfunction and Asthma

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2022-02-0113

PRE

Treatment effectiveness for Vocal Cord Dysfunction in adults and adolescents: A systematic review

CLINICAL AND EXPERIMENTAL ALLERGY

IF5.2

2021-11-0428

PREAI

Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen

BREAST CANCER RESEARCH AND TREATMENT

IF3

2012-12-0837

OAAI

Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors

INVESTIGATIONAL NEW DRUGS

IF2.7

2010-09-2239

PREAI